Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy
Crossref DOI link: https://doi.org/10.1186/s12935-018-0676-y
Published Online: 2018-11-08
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Icard, Philippe
Fournel, Ludovic http://orcid.org/0000-0003-4530-9039
Coquerel, Antoine
Gligorov, Joseph
Alifano, Marco
Lincet, Hubert
Text and Data Mining valid from 2018-11-08
Article History
Received: 13 August 2018
Accepted: 4 November 2018
First Online: 8 November 2018